These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 204819)

  • 21. Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole.
    Son K; Kew M; Rabson AR
    Cancer; 1982 Dec; 50(12):2820-5. PubMed ID: 6182983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lymphocyte-mediated cytotoxicity. II. Effect of prednisolone on cytotoxicity of lymphocytes from normal persons (author's transl)].
    Nemoto R
    Nihon Hinyokika Gakkai Zasshi; 1979 Jul; 70(7):756-64. PubMed ID: 502101
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.
    Baldwin RW; Embleton MJ; Robins RA
    Int J Cancer; 1973 Jan; 11(1):1-10. PubMed ID: 4133609
    [No Abstract]   [Full Text] [Related]  

  • 24. [Detection of HBs Ag in bone's metastatic malignant hepatoma (author's transl)].
    Doury JC; Roche JC; Brisou B
    Nouv Presse Med; 1977 Sep; 6(31):2751-2. PubMed ID: 201921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysis by LT complexes associated with Ig-like receptor(s).
    Yamamoto RS; Hiserodt JC; Granger GA
    Cell Immunol; 1979 Jul; 45(2):261-75. PubMed ID: 157226
    [No Abstract]   [Full Text] [Related]  

  • 26. Spontaneous and antibody-dependent cellular immune reactions to ethanol-altered hepatoma cells.
    Poralla T; Hütteroth TH; Knuth A; Staritz M; Dienes HP; Meyer zum Büschenfelde KH
    Liver; 1987 Feb; 7(1):50-7. PubMed ID: 3033423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.
    Baldwin RW; Price MR; Robins RA
    Nat New Biol; 1972 Aug; 238(84):185-6. PubMed ID: 4340574
    [No Abstract]   [Full Text] [Related]  

  • 28. [Amino acids requirement of human peripheral lymphocytes undergoing PHA-induced blastoid transformation (author's transl)].
    Ono R; Ezaki K; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1973 Dec; 36(6):893-8. PubMed ID: 4800011
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serum complement profile and its clinical significance in patients with hepatocellular carcinoma and liver cirrhosis (author's transl)].
    Matsumura N; Tagami H; Hotta T; Takemura S; Yoshikawa T; Kondo M
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1753-9. PubMed ID: 6275149
    [No Abstract]   [Full Text] [Related]  

  • 30. [Histone phosphorylation of human lymphocytes after PHA stimulation in relation to age (author's transl)].
    Lutz H; Konersmann T; Ermini M
    Aktuelle Gerontol; 1977 May; 7(5):257-61. PubMed ID: 18039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis B virus surface antigen (HBsAg) in human hepatocellular carcinoma and its surrounding tissues of liver (author's transl)].
    Wang WL; Zang JS; Wang BY; Liu WB; Zhu CW; Ding HY; Yan PS; Liu YF
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):101-5. PubMed ID: 233358
    [No Abstract]   [Full Text] [Related]  

  • 32. [PHA induced cytotoxicity. 1. Its concept and clinical significance (author's transl)].
    Hata M; Aoki S; Jitsukawa S; Yoshida T; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1977 Mar; 68(3):225-30. PubMed ID: 558447
    [No Abstract]   [Full Text] [Related]  

  • 33. [alpha 1-fetoprotein and Tennessee antigen in hepatocellular carcinomas and in metastatic liver cancer (author's transl)].
    Polterauer P; Müller M
    Wien Klin Wochenschr; 1982 Feb; 94(4):102-5. PubMed ID: 6177106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.
    Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U
    Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. II. Activation by phytohemagglutinin.
    Stejskal V; Lindberg S; Holm G; Perlmann P
    Cell Immunol; 1973 Jul; 8(1):82-92. PubMed ID: 4199809
    [No Abstract]   [Full Text] [Related]  

  • 36. [Morphological demonstration of hepatitis B virus surface antigen in liver cirrhosis, fibrosis and hepatocellular carcinoma (author's transl)].
    Chlumská A; Kautzner J
    Cas Lek Cesk; 1981 Jun; 120(23):689-92. PubMed ID: 6265089
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxicity by NK-like cells from hepatitis B-immune patients to a human hepatoma cell line secreting HBsAg.
    Chin TW; Hollinger FB; Rich RR; Troisi CL; Dreesman GR; Melnick JL
    J Immunol; 1983 Jan; 130(1):173-80. PubMed ID: 6292302
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
    Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
    Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour-specific antibody neutralization of factors in rat hepatoma-bearer serum which abrogate lymph-node-cell cytotoxicity.
    Robins RA; Baldwin RW
    Int J Cancer; 1974 Nov; 14(5):589-97. PubMed ID: 4376528
    [No Abstract]   [Full Text] [Related]  

  • 40. Impaired cytotoxicity of lymphocytes from patients with cancer.
    Suciu-Foca N; Buda JA; Herter F; Molinaro A; Broell J; Reemtsma K
    J Surg Oncol; 1976; 8(1):75-81. PubMed ID: 1249943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.